Erik Harris

Erik Harris

Directeur/Membre du Conseil chez REZOLUTE, INC.

Fortune : 4 M $ au 30/06/2026

56 ans
Health Technology
Consumer Services
Commercial Services

Profil

Erik C.
Harris
is an Independent Director at Rezolute, Inc. since 2025, Chief Commercial Officer & Executive Vice President at Ultragenyx Pharmaceutical, Inc. since 2019, and a Trustee at East Bay Zoological Society.
Former roles include Independent Director at Denali Therapeutics, Inc. from 2022 to 2025, Independent Director at Inozyme Pharma, Inc. from 2024 to 2025, Senior Director-Marketing & Sales at Elan Corp.
Plc, Manager-Sales & Marketing at Bristol Myers Squibb Co. from 1999 to 2001, Head-Sales & Marketing at Genentech, Inc. from 2003 to 2007, Vice President-Pulmonology Marketing at InterMune, Inc. from 2009 to 2010, and Vice President-Marketing & Sales at Crescendo Bioscience LLC from 2011 to 2017.
Education includes undergraduate studies at the United States Naval Academy and an MBA from The Wharton School of the University of Pennsylvania.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
16/04/2026 118 410 ( 0,12 % ) 4 M $ 30/06/2026
19/11/2025 0 ( -.--% ) - $ 30/06/2026

Postes actifs de Erik Harris

SociétésPosteDébut
ULTRAGENYX PHARMACEUTICAL INC. Corporate Officer/Principal 01/01/2017
REZOLUTE, INC. Directeur/Membre du Conseil 25/03/2025
Directeur/Membre du Conseil -

Anciens postes connus de Erik Harris

SociétésPosteFin
INOZYME PHARMA, INC. Directeur/Membre du Conseil 01/07/2025
DENALI THERAPEUTICS INC. Directeur/Membre du Conseil 03/06/2025
Sales & Marketing 01/06/2017
INTERMUNE INC Sales & Marketing 01/08/2010
Corporate Officer/Principal 01/01/2007
Voir l'expérience en détail de Erik Harris

Formation de Erik Harris

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

65

Relations au 1er degré

12

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées12

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Consumer Services

Consumer Services

Health Technology

Consumer Services

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Erik Harris
🔇